Corcept Therapeutics Incorporated (CORT)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 106,140 | 101,418 | 112,512 | 106,011 | 94,181 |
| Total assets | US$ in thousands | 621,517 | 583,430 | 423,756 | 571,731 | 412,312 |
| ROA | 17.08% | 17.38% | 26.55% | 18.54% | 22.84% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $106,140K ÷ $621,517K
= 17.08%
Corcept Therapeutics Inc has demonstrated varying levels of return on assets (ROA) over the past five years. The ROA was 17.08% in 2023, slightly lower than the previous year's ROA of 17.38%. In 2021, the ROA was at its peak at 26.55%, showing a strong performance in effectively utilizing its assets to generate profits. The ROA then decreased to 18.54% in 2020 but increased to 22.84% in 2019.
Overall, the trend in ROA indicates that Corcept Therapeutics Inc has been effectively managing its assets to generate profits, with fluctuations in performance year over year. Investors and stakeholders may monitor ROA as an indicator of the company's efficiency in generating profits relative to its total assets.
Peer comparison
Dec 31, 2023